TM Logo Final ® 0819.inddTutera MedicalTM Logo Final ® 0819.inddTM Logo Final ® 0819.indd
  • Women
  • Men
  • Wellness & Beauty
    • Hormone Pellet Therapy
    • Botox
    • Viveve Treatment
    • Juvederm
    • LIFEFIT™
    • Rodan & Fields
    • UVee Home Play
    • SottoPelle®
    • CBD Products
  • About Us
    • 2019 Holiday Schedule
    • Lab Hours
    • Patient Forms
    • Blog
    • News
      • Events
      • Videos
  • Providers
  • Get In Touch
  • Patient Portal
Holiday Open House 2019 Pre Sale Event
November 12, 2018
Are your hormones holding you back?
November 13, 2018
Published by Dani at November 12, 2018
Categories
  • Anti Aging
  • Lifestyle
  • Menopause
Tags
  • Juvederm

PROMOTION EXPIRED

To get  a $75 coupon on any Juvéderm 1ml filler

Expires on November 30, 2018; rebate must be used by 12/31/18

 

JUVÉDERM® Collection of Fillers Important Information

INDICATIONS JUVÉDERM VOLUMA® XC injectable gel is indicated for deep (subcutaneous and/or supraperiosteal) injection for cheek augmentation to correct age-related volume deficit in the mid-face in adults over the age of 21. JUVÉDERM® Ultra XC and JUVÉDERM® Ultra Plus XC injectable gels are indicated for injection into the mid-to-deep dermis for correction of moderate to severe facial wrinkles and folds (such as nasolabial folds). JUVÉDERM VOLLURE™ XC injectable gel is indicated for injection into the mid-to-deep dermis for correction of moderate to severe facial wrinkles and folds (such as nasolabial folds) in adults over the age of 21. JUVÉDERM® Ultra XC injectable gel is indicated for injection into the lips and perioral area for lip augmentation in adults over the age of 21. JUVÉDERM VOLBELLA® XC injectable gel is indicated for injection into the lips for lip augmentation and for correction of perioral rhytids in adults over the age of 21. IMPORTANT SAFETY INFORMATION CONTRAINDICATIONS These products should not be used in patients who have severe allergies, marked by a history of anaphylaxis or history or presence of multiple severe allergies, and should not be used in patients with a history of allergies to Gram-positive bacterial proteins or lidocaine contained in these products. WARNINGS

  • Do not inject into blood vessels. Introduction of these products into the vasculature may lead to embolization, occlusion of the vessels, ischemia, or infarction. Take extra care when injecting soft-tissue fillers; for example, inject the product slowly and apply the least amount of pressure necessary. Rare, but serious, adverse events associated with the intravascular injection of soft-tissue fillers in the face have been reported and include temporary or permanent vision impairment, blindness, cerebral ischemia or cerebral hemorrhage leading to stroke, skin necrosis, and damage to underlying facial structures. Immediately stop the injection if a patient exhibits any of the following symptoms: changes in vision, signs of a stroke, blanching of the skin, unusual pain during or shortly after the procedure. Patients should receive prompt medical attention and, possibly, evaluation by an appropriate healthcare professional specialist should an intravascular injection occur
  • Product use at specific sites in which an active inflammatory process (skin eruptions such as cysts, pimples, rashes, or hives) or infection is present should be deferred until the underlying process has been controlled

PRECAUTIONS

  • In order to minimize the risk of potential complications, these products should only be used by healthcare professionals who have appropriate training, experience, and knowledge of facial anatomy
  • Healthcare professionals are encouraged to discuss the potential risks of soft-tissue injections with their patients prior to treatment and ensure that patients are aware of signs and symptoms of potential complications
  • The safety and effectiveness for the treatment of anatomic regions other than the mid-face with JUVÉDERM VOLUMA® XC; facial wrinkles and folds with JUVÉDERM® Ultra XC, JUVÉDERM® Ultra Plus XC, and JUVÉDERM VOLLURE™ XC; and the lips and perioral area with JUVÉDERM® Ultra XC and JUVÉDERM VOLBELLA® XC have not been established in controlled clinical studies
  • As with all transcutaneous procedures, dermal filler implantation carries a risk of infection. Follow standard precautions associated with injectable materials
  • The safety for use during pregnancy, in breastfeeding females, and in patients with known susceptibility to keloid formation, hypertrophic scarring, and pigmentation disorders has not been studied
  • The safety for use of JUVÉDERM VOLUMA® XC in patients under 35 or over 65 years, JUVÉDERM® Ultra XC and JUVÉDERM® Ultra Plus XC in patients under 18 years, and JUVÉDERM VOLLURE™ XC and JUVÉDERM VOLBELLA® XC in patients under 22 years has not been established
  • Use with caution in patients on immunosuppressive therapy
  • Patients who are using products that can prolong bleeding (such as aspirin, nonsteroidal anti-inflammatory drugs, and warfarin) may experience increased bruising or bleeding at treatment sites
  • If laser treatment, chemical peel, or any other procedure based on active dermal response is considered after treatment, or if the product is administered before the skin has healed completely, there is a possible risk of an inflammatory reaction at the treatment site
  • Patients who experience skin injury near the site of implantation may be at a higher risk for adverse events
  • The safety of JUVÉDERM VOLUMA® XC injectable gel for use in patients with very thin skin in the mid-face has not been established
  • Patients may experience late onset nodules with use of dermal fillers, including JUVÉDERM VOLUMA® XC
  • Patients may experience late onset adverse events with use of dermal fillers

ADVERSE EVENTS The most commonly reported side effects for JUVÉDERM® injectable gels were injection-site redness, swelling, pain, tenderness, firmness, lumps/bumps, bruising, discoloration, and itching. For JUVÉDERM VOLBELLA® XC, dryness was also reported. For JUVÉDERM VOLUMA® XC, side effects were predominantly moderate in severity, with duration of 2 to 4 weeks; for JUVÉDERM® Ultra XC , JUVÉDERM® Ultra Plus XC, or JUVÉDERM VOLLURE™ XC, they were mostly mild or moderate in severity, with duration of 14 days or less; and for JUVÉDERM VOLBELLA® XC, they were predominantly mild or moderate, with duration of 30 days or less. To report an adverse reaction with any product in the JUVÉDERM® Collection, please call Allergan at 1-800-433-8871. Please visit JuvedermDFU.com for more information.

Products in the JUVÉDERM® Collection are available by prescription only.

Share
0
Dani
Dani

Related posts

November 18, 2019

CarolAnn Tutera Guest Host on 99.9KEZ


Read more
February 27, 2019

Curious about Pellet Therapy?


Read more
February 27, 2019

And the Oscar Goes to to…..


Read more

Comments are closed.

About Us

Tutera Medical offers bioidentical hormone replacement pellet therapy for both men and women. We are part of the SottoPelle network, founded by bioidentical hormone replacement pioneer Dr. Gino Tutera.

2018 North Valley Women in Business Badge

Links

  • Women
  • Men
  • Wellness and Beauty
  • Patient Forms
  • Providers
  • Get In Touch
    • Privacy Policy
    • Disclaimer
    • Terms of Use
  • Lab Hours
  • 2019 Holiday Schedule
  • Patient Portal

Therapy

  • Hormone Pellet Therapy
  • Hormone Replacement Therapy
  • Women
  • Men
  • Botox
  • Viveve Treatment
  • Juvederm
  • Rodan & Fields

Lets Get Connected




Adventures in Aging Podcast

© Copyright 2019 - Tutera Medical®
MEDICAL DISCLAIMER: TUTERAMEDICAL.COM is committed to making our directory helpful and accessible for everyone. We have created a document that explains the Terms of Service for this directory and website. Please be advised that all providers will note any sponsored listings, affiliations, training or otherwise. Thank you for reading and helping us to responsibly share BHRT information. Physician profiles are for educational or informational use only and not meant as a recommendation of any specific doctor and/or medical practice, or substitution for any medical advice.

For more information, please visit: tuteramedical.com/termsofservice

DISCLAIMER The medical information on this site is provided as an information resource only, and is not to be used or relied on for any diagnostic or treatment purposes. This information is not intended to be patient education, does not create any patient-physician relationship, and should not be used as a substitute for professional diagnosis and/or treatment. Please consult your health care provider, or SottoPelle for an appointment, before making any Tutera Medical expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. SottoPelle does not specifically endorse any third party test, treatment, and/or procedure mentioned on the site, other than their own therapies. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by SottoPelle. If you do not agree to the foregoing terms and conditions, you should not enter this site.
[contact-form-7 id="656" title="Schedule a Consultation"]